Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
Captor Therapeutics Spolka Akcyjna
Market Cap: zł183.6m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł33.20
7D
-1.2%
1Y
-58.5%
Selvita
Market Cap: zł497.4m
Operates as a contract research organization worldwide.
SLV
zł27.10
7D
-2.2%
1Y
-59.6%